NVIDIA AI Podcast How Agentic AI Shortens Drug Development and Boosts Patient Outcomes - Ep. 277
30 snips
Oct 15, 2025 Avinob Roy and Raja Shankar from IQVIA dive into the revolutionary potential of agentic AI in pharmaceuticals. They discuss how intelligent automation can drastically shorten clinical trials, enhance commercialization strategies, and lead to better patient care. The duo highlights the importance of optimizing treatment choices and personalizing patient engagement through data-driven insights. Additionally, they touch on the challenges of data security and the need for effective performance measurement to ensure successful AI application in healthcare.
AI Snips
Chapters
Transcript
Episode notes
Agents Chain Tasks Across Complex Workflows
- Agentic AI composes multi-step workflows by chaining agents that call tools and pass outputs between each other.
- That capability lets IQVIA automate complex clinical processes that were previously manual and slow.
Simulate Trials And Automate Repetitive Tasks
- Two major opportunities are clinical development simulation and clinical trial automation with agents.
- Simulating trials and automating repetitive tasks can raise success rates and cut trial time and cost.
Agents Tame Commercial Data Chaos
- Commercial teams face data chaos from many sources, and agents can stitch heterogeneous data to speed decisions.
- Agents help strategy, operationalization, and engagement so launches reach the right patients faster.